approval
saveLORBRENA (LORLATINIB) — FDA approval
community read0 votes
Sponsor: PFIZER. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 6
- approvalLORBRENA (LORLATINIB) — FDA approvalJan 29, 2026 · 248d ago
- approvalLORBRENA (LORLATINIB) — FDA approvalMar 3, 2021 · 2041d ago
- approvalLORBRENA (LORLATINIB) — FDA approvalFeb 26, 2021 · 2046d ago
- approvalLORBRENA (LORLATINIB) — FDA approvalJan 22, 2021 · 2081d ago
- approvalLORBRENA (LORLATINIB) — FDA approvalMay 29, 2020 · 2319d ago
- approvalLORBRENA (LORLATINIB) — FDA approvalNov 2, 2018 · 2893d ago
same company · ±60 days · 6
- approvaltofacitinib citrate ER: XELJANZ (TOFACITINIB CITRATE) — FDA approvalFeb 21, 2025
- approvaltofacitinib citrate ER: XELJANZ XR (TOFACITINIB CITRATE) — FDA approvalFeb 21, 2025
- approvalPAXLOVID (COPACKAGED): PAXLOVID (COPACKAGED) (NIRMATRELVIR) — FDA approvalFeb 12, 2025
- approvalPAXLOVID (COPACKAGED): PAXLOVID (COPACKAGED) (NIRMATRELVIR) — FDA approvalJan 31, 2025
- approvalUNASYN: UNASYN (AMPICILLIN SODIUM) — FDA approvalJan 31, 2025
- recallAspen Biopharma Labs Pvt., Ltd. recall (Cls II)Mar 19, 2025
comments(0)
5-min edit window · permanent after that